Opinion
Hormones after cancer: Are they safe?
Hormonal therapy is safe, even beneficial, for many patients with a history of gynecologic cancer, and can significantly improve their quality of...
Opinion
The medical management of early-stage endometrial cancer: When surgery isn’t possible, or desired
Hormonal therapy has long been identified as a highly effective systemic therapy for endometrial cancers, particularly those that are low grade...
Opinion
Optimizing ‘optimal’ in ovarian cancer cytoreduction
While pafolacianine promises to move us closer to a true “R0” (negative margins) resection of ovarian cancer, is this even a feasible goal in a...
Opinion
Evaluating phantom hCG and low-level hCG elevations in the nonpregnant patient
Misdiagnosis and inappropriate treatment of benign, low-level hCG levels with unnecessary chemotherapy is problematic mismanagement of gestational...
Opinion
Management of advanced endometrial cancer
Arguably more important than surgical interventions, access to molecularly targeted systemic therapy is likely to bring the best outcomes for...
Opinion
Recommendations from a gynecologic oncologist to a general ob.gyn., part 2
While screening tests may not be appropriate for all patients, all patients should be asked about the early symptoms of ovarian cancer because...
Opinion
Decision making regarding LEEP versus cone biopsy for excision of cervical dysplasia
While both techniques are associated with equivalent efficacy in disease control, each has its virtues and advantages, and clinical judgment is...
Opinion
Endometriosis-associated ovarian cancer
A woman with endometriosis has a two- to threefold increased risk of developing epithelial ovarian cancer, compared with nonaffected women.
Opinion
Intraoperative rupture of ovarian cancer: Does it worsen outcomes?
Intact removal of an ovarian cyst is a well-established gynecologic surgical principle because ovarian cancer is definitively diagnosed only in...
Opinion
Are uterine manipulators safe for gynecologic cancer surgery?
Prospective studies are needed to determine if use of these instruments truly is safe or not.
Opinion
Treating VIN while preventing recurrence
VIN is particularly problematic because more than a quarter of patients will experience recurrence of their disease after primary therapy.
Opinion
Disparity in endometrial cancer outcomes: What can we do?
Black women report symptoms less, have more delays in diagnosis, and experience more frequent deviations from guideline-directed diagnostics.
Opinion
Ovarian cancer and perineal talc exposure: An epidemiologic dilemma
Recall bias and lack of an established biologic mechanism are a few reasons perineal talc exposure isn’t considered a definitive cause of ovarian...
Opinion
Discuss compounded bioidentical hormones and cancer risk
Patients who desire compounded bioidentical hormone preparations should be counseled that little is known about the safety of these preparations,...